Sponsor:
Dana-Farber Cancer Institute
Code:
NCT05721248
Conditions
Breast Cancer
Metastatic Breast Cancer
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cessation of anti-HER2 treatment
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2024-10-01.